Form 8-K - Current report:
SEC Accession No. 0000950170-25-035924
Filing Date
2025-03-10
Accepted
2025-03-10 08:00:12
Documents
12
Period of Report
2025-03-08
Items
Item 5.01: Changes in Control of Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ubx-20250308.htm   iXBRL 8-K 68675
2 EX-99.1 ubx-ex99_1.htm EX-99.1 15302
  Complete submission text file 0000950170-25-035924.txt   201798

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ubx-20250308.xsd EX-101.SCH 25006
14 EXTRACTED XBRL INSTANCE DOCUMENT ubx-20250308_htm.xml XML 4539
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

EIN.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 25722191
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)